PhaseBio Pharmaceuticals (PHAS) PT Slashed to $10 by Needham, Buy Reiterated, Sees bentracimab's Potential Undervalued Despite Capital Overhang

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. NAVN
4. HUMA
5. CHWY
6. USO
7. SPCX
8. cASY
9. PCT
10. INTC

Go back to PhaseBio Pharmaceuticals (PHAS) PT Slashed to $10 by Needham, Buy Reiterated, Sees bentracimab's Potential Undervalued Despite Capital Overhang
(NASDAQ: PHAS) Delayed: 0.07 --0 (-0%)
Previous Close $0.07    52 Week High $ 
Open $16.08    52 Week Low $ 
Day High $0.07    P/E N/A 
Day Low $0.07    EPS $ 
Volume 94,799